BMPR2 and pulmonary arterial hypertension: It has been shown that TNF‐α can further promote the development of PAH by reducing the BMPR2 expression (a key factor in lung remodeling) in PASMCs, and baicalin can regulate the TNF‐α signaling pathway to prevent experimental PAH [35].